It has been revealed by experts that the post-COVID vaccine syndrome could actually be a psychological disease. Check out the latest reports about the matter below.
Post-COVID vaccine syndrome, a psychological disease
According to a recent German study led by Dr. Fritz Boege, a professor of clinical chemistry and laboratory medicine at the University Hospital of Düsseldorf, people who experience persistent symptoms for up to five months after receiving the COVID-19 vaccine have different immune protein levels than those who are vaccinated but remain asymptomatic.
These persistent symptoms are known as Post-COVID vaccine syndrome (PACVS) and can last for months to years after receiving the vaccine.
Common symptoms of PACVS include fatigue, brain fog, post-exertional malaise, and abnormalities in the heart, nervous system, muscles, and the gut. Dr. Keith Berkowitz, an internal physician who was not involved in the study, stated that “It’s really the first recognition that biomarkers may be involved in [COVID-19 vaccine injury]” to The Epoch Times.
“No. 2, they’re looking five to six months post-vaccination, and that really dispels the literature that these side effects are transient.”
The study compared PACVS patients to individuals who received two doses of mRNA vaccine and did not show any symptoms.
The researchers discovered that PACVS patients had elevated levels of cytokines that trigger inflammation, increased antibodies that might interfere with fluid balance and cardiovascular regulation, and decreased antibodies that are associated with immune balance.
“PACVS is currently not/rarely diagnosed in terms of a [physical] disease. Instead, PACVS cases tend to be classified as psychosomatic or discarded as irrelevant or imaginary,” the authors wrote.
The study provides “evidence of PACVS as a [physical] disease,” they concluded.
In a recent study, 191 people diagnosed with persistent dysautonomia and chronic fatigue syndrome were compared to 89 healthy controls.
The blood samples of the controls were taken both before and after vaccination, and they did not show any pathological symptoms following vaccination.
The study found that cytokine levels of IL-6 and IL-8, which promote inflammation and are linked with the formation of blood clots, were significantly higher in PACVS patients.
Further, PACVS patients had significantly higher levels of AT1R and MAS 1 antibodies and lower levels of IL-1-Rb and alpha-2b-adr-R antibodies.
The reverse was observed in the healthy control group. The AT1R and MAS 1 antibodies are associated with the body’s fluid balance and cardiovascular regulation, and high antibody levels against this system are connected to dysautonomia, heart failure, chronic fatigue, and severe COVID-19.
You can check out more official info about the matter in the original notes.
